Etilevodopa

Etilevodopa
Clinical data
Other names	TV-1203; Levodopa ethyl ester; L-DOPA ethyl ester
ATC code	N04BA06 (WHO) (combination with decarboxylase inhibitor);
Identifiers
	IUPAC name ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate;
CAS Number	37178-37-3 ;
PubChem CID	170345;
ChemSpider	148944 ;
UNII	895X917GYE;
KEGG	D04097 ;
CompTox Dashboard (EPA)	DTXSID10905092 ;
ECHA InfoCard	100.223.003
Chemical and physical data
Formula	C11H15NO4
Molar mass	225.244 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC)[C@@H](N)Cc1cc(O)c(O)cc1;
	InChI InChI=1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1 ; Key:NULMGOSOSZBEQL-QMMMGPOBSA-N ;
	(verify)

Etilevodopa (developmental code name TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.^[1] It is the ethyl ester of levodopa. It was never marketed.

References

^ Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E (November–December 2003). "Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study". Clinical Neuropharmacology. 26 (6): 322–6. doi:10.1097/00002826-200311000-00012. PMID 14646613. S2CID 23992241.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.